Please note: AABB reserves the right to make updates to this program.
Wednesday, July 24, 2019
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 19EL-457 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate
Director/Moderator: Isabella W. Martin, MD, Assistant Professor of Pathology, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Speaker: Evan Bloch, Assistant Professor, Johns Hopkins University School of Medicine, Associate Director, Transfusion Medicine, Johns Hopkins Medical Institutes, Baltimore, MD
After participating in this educational activity, participants should be able to:
- Describe the clinical relevance and geographic distribution of Babesia, Zika virus and Dengue virus.
- Describe assays available for testing blood products for Babesia, Zika virus and Dengue virus.
- Recognize the impact on the US blood supply of screening and testing for emerging transfusion-transmitted pathogens.
This program will review the clinical relevance and geographic distribution of the recently emerging transfusion-transmitted pathogens Babesia, Zika virus and Dengue virus. The current state of regulatory requirements for screening and testing for these infections will be discussed as well as the impact of these interventions on the US blood supply.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||
Continuing Education Credit
AABB estimates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Dr. Bloch’s expertise is in the field of neglected (e.g. Babesia) and emerging infectious diseases (e.g. Zika virus), particularly in the context of blood transfusion safety. He has participated in studies to develop both antibody and molecular tests for detection of Babesia. He is a member of the International Society of Blood Transfusion infectious disease working party. He has consulted on transfusion policy and development of clinical transfusion guidelines and hopes to use blood transfusion as a platform for infectious disease surveillance so as to guide programmatic support, particularly in low-resource settings.